Cargando…

Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI)

BACKGROUND: The International Prognostic Index (IPI) is used to determine prognosis in diffuse large B-cell lymphoma (DLBCL). One of the determinants of IPI is the stage of disease with bone marrow involvement being classified as stage IV. For the IPI, involvement on bone marrow is traditionally def...

Descripción completa

Detalles Bibliográficos
Autores principales: Talaulikar, Dipti, Shadbolt, Bruce, Dahlstrom, Jane E, McDonald, Anne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786909/
https://www.ncbi.nlm.nih.gov/pubmed/19930611
http://dx.doi.org/10.1186/1756-8722-2-49